首页 › 基金 › Redmile Group, LLC › BMRN

Redmile Group, LLC 对 BMRN 的持仓历史

BIOMARIN PHARMACEUTICAL INC COM · 医疗保健

Redmile Group, LLC 在 Q2 2026 的 13F 申报中披露持有 BMRN(BIOMARIN PHARMACEUTICAL INC COM)265,169 股,市值约 US$15.2M,约占其申报组合的 1.02%,在其申报持仓中市值排名第 22 位。 Redmile Group, LLC 最近 2 个申报季度中有 2 个季度披露了 BMRN 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q2 2026)265.17K 股
申报持仓市值$15.17M
组合权重1.02%
首次申报Q1 2026
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Redmile Group, LLC 对 BMRN 的持仓演变

Redmile Group, LLC 于 Q1 2026 首次披露 BMRN 持仓:173,859 股(约 US$9.8M)。 该持仓在 Q2 2026 达到峰值 265,169 股,市值约 US$15.2M。 在 2 次申报中,Redmile Group, LLC 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 265,169 股、市值约 US$15.2M,环比增持 91,310 股。。 持仓曾出现大幅变动:Q2 2026 增持约 53% (随后一个季度股价上涨 5%)。

逐季持仓明细

季度股数金额变化
Q1 2026 173.86K $9.82M 新进
Q2 2026 265.17K $15.17M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 BMRN 与 13F 数据

BMRN(BIOMARIN PHARMACEUTICAL INC COM)属于医疗保健行业。我们追踪的基金中还有 27 只申报持有 BMRN,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$812.0M), 维京环球投资 (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BMRN 的基金

查看 BMRN 的全部基金持有人 →

常见问题

How long has Redmile Group, LLC held BMRN?

Redmile Group, LLC has disclosed BMRN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Redmile Group, LLC's current position in BMRN?

As of Q2 2026, Redmile Group, LLC holds 265.17K shares of BMRN (BIOMARIN PHARMACEUTICAL INC COM), valued at $15.17M, representing 1.02% of its reported portfolio and ranking #22.

Has Redmile Group, LLC been buying or selling BMRN?

In the latest 13F filing (Q2 2026), Redmile Group, LLC increased its position in BMRN. The position peaked in Q2 2026 at 265.17K shares.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, 维京环球投资, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.